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Abstract: Tumors frequently contain hypoxic regions that result from a shortage of oxygen due 
to poorly organized tumor vasculature. Cancer cells in these areas are resistant to radiation- and 
chemotherapy, limiting the treatment efficacy. Macrophages have inherent hypoxia-targeting 
ability and hold great advantages for targeted delivery of anticancer therapeutics to cancer cells 
in hypoxic areas. However, most anticancer drugs cannot be directly loaded into macrophages 
because of their toxicity. In this work, we designed a novel drug delivery vehicle by hybridizing 
macrophages with nanoparticles through cell surface modification. Nanoparticles immobilized 
on the cell surface provide numerous new sites for anticancer drug loading, hence potentially 
minimizing the toxic effect of anticancer drugs on the viability and hypoxia-targeting ability 
of the macrophage vehicles. In particular, quantum dots and 5-(aminoacetamido) fluorescein-
labeled polyamidoamine dendrimer G4.5, both of which were coated with amine-derivatized 
polyethylene glycol, were immobilized to the sodium periodate-treated surface of RAW264.7 
macrophages through a transient Schiff base linkage. Further, a reducing agent, sodium cyanobo-
rohydride, was applied to reduce Schiff bases to stable secondary amine linkages. The distribution 
of nanoparticles on the cell surface was confirmed by fluorescence imaging, and it was found to 
be dependent on the stability of the linkages coupling nanoparticles to the cell surface.
Keywords: anticancer drug, cellular vehicle, confocal microscopy, dendrimer, drug delivery, 
hypoxia, nanotechnology
Introduction
The cell membrane, a semipermeable lipid bilayer, defines the cell boundary and 
consists of lipids, proteins and carbohydrates that are responsible for selective uptake 
of molecules, cell–cell interactions, cell–matrix interactions, and many other vital 
cell activities. Because of the importance of cell surface interactions to cell and tissue 
function, various cell surface engineering approaches have been explored to modify 
the cell surface to manipulate cell behavior and function.1,2
Considerable progress has been made in introducing nonnative chemical species 
to the cell membrane, permitting a wide range of applications in biology, medicine, 
drug delivery, and tissue engineering.3 A molecule of interest can be attached to the cell 
surface through a fatty tether including glycosyl-phosphatidylinositol (GPI)-anchored 
proteins4 and cholesterol-tethered compounds.5 A viable alternative is to apply 
enzyme-catalyzed chemical reactions to modify carbohydrates on the cell surface. 
For example, existing surface glycoforms can be utilized as acceptors for reactions 
with an exogenously applied glycosyltransferase and appropriate activated sugar 
donor.1,6 Sialic acids are the most common terminal sugar residue on the cell surfaces International Journal of Nanomedicine 2010:5 26
Holden et al Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
and play an important role in cell adhesion and recognition. 
Unnatural sialic acid precursors can be incorporated into 
cell surface glycoforms by metabolic engineering.7 Direct 
covalent reactions can also be applied to enable chemical 
modification of cell surfaces.8,9 One possible approach is to 
couple biomolecules of interest to the cell surface via reac-
tive cell surface groups such as aldehydes and ketones.10,11 
The generation of these reactive cell surface groups may be 
achieved by direct chemical or enzymatic treatment, or by 
the metabolic incorporation of an unnatural molecule that 
contains the chosen chemical species.
Cell surface engineering has generated tremendous 
advantages for drug delivery and tissue engineering. For 
example, a synthetic adenovirus receptor inserted to the cell 
surface via a metabolic engineering approach facilitates the 
entrance of adenovirus into cells that are normally resistant to 
infection by this virus.12 Uptake of exogenous proteins could 
be enhanced by inserting appropriate synthetic receptors.13 
Selectively killing tumor cells could be realized by control-
ling the targeting of an antibody through tagging tumor cells 
with a non-natural sugar into the polysialic acid molecules 
on the cell surface.14 Cell surface modification approaches 
have also been applied to generate three-dimensional cell 
aggregates or tissue-engineered constructs through cell cross-
linking.15 A recent study reported that polyethylene glycol 
(PEG) can be attached to the surface of islets to circumvent 
immune rejection during transplantation of pancreatic islets 
from donor to a patient.9
In this work, we designed a novel hypoxia-targeted drug 
delivery vehicle by hybridizing macrophages with nanopar-
ticles through cell surface modification. Tumors frequently 
contain hypoxic regions that result from a shortage of oxygen 
due to poorly organized tumor vasculature. Cancer cells in 
these areas are resistant to radiation- and chemotherapy, 
limiting the treatment efficacy.16 Macrophages and mono-
cytes have inherent hypoxia-targeting ability and hold great 
advantages for selective delivery of anticancer therapeutics to 
cancer cells in hypoxic areas.16–19 However, most anticancer 
drugs cannot be directly loaded into macrophages or mono-
cytes because of their toxicity. Hybridizing a macrophage 
or monocyte cellular vehicle with a synthetic carrier, par-
ticularly nanoparticles, may represent a novel approach for 
effective delivery of anticancer drugs to hypoxic regions in 
solid tumors. Immobilizing nanoparticles on the cell surface 
provide numerous new sites for anticancer drug loading, 
hence potentially minimizing the toxic effect of anticancer 
drugs on the viability and hypoxia-targeting ability of the 
macrophage or monocyte vehicles.
The focus of the current work was to demonstrate the 
feasibility of immobilizing nanoparticles including polyami-
doamine (PAMAM) dendrimers and quantum dots (Qdots) 
to the macrophage surface through cell surface chemical 
modification. Dendrimers are highly branched macromol-
ecules with low polydispersity and well-defined surface 
functionality. Utility of dendrimers in this work allowed 
us to take advantage of their versatility to explore optimal 
approaches for cell-nanoparticle hybridization and realize a 
high drug payload and assembly of multiple functional enti-
ties necessary for hybridization and drug delivery. Commer-
cially available quantum dots coated with amine-derivatized 
PEG was also studied for cell-nanoparticle hybridization. 
Qdots have been explored for fluorescence imaging of living 
cells.20 Although the limited number of surface groups of 
Qdots is not advantageous for drug loading, hybridizing 
cells with Qdots possessing long-term photostability offers a 
noninvasive way for cell tracking in vivo and would provide 
further evidence to demonstrate the feasibility of the cell-
nanoparticle hybridization approach explored in this work.
Experimental
Materials
Qdot® 525 ITK™ amino (PEG) quantum dots (simply referred 
to as QD525) and 5-(aminoacetamido) fluorescein (AAF) 
were purchased from Invitrogen (Carlsbad, CA). PAMAM 
dendrimer G4.5 was purchased from Dendritech (Midland, MI). 
PEG diamine (MW= ∼3350 g mol-1), N-hydroxysuccinimide 
(NHS), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
hydrochloride (EDC), sodium cyanoborohydride (NaCNBH3), 
sodium periodate (NaIO4), and sodium phosphate buffer 
(10×) were purchased from Sigma-Aldrich (St. Louis, MO). 
4',6-diamidino-2-phenylindole (DAPI), Dulbecco’s modified 
Eagle medium (DMEM), sodium hydroxide, paraformalde-
hyde, phosphate-buffered saline (PBS), fetal bovine serum 
(FBS), penicillin, and Trypan blue were purchased from Fisher 
Scientific (Pittsburgh, PA).
Preparation of AAF-labeled Pegylated 
g4.5 dendrimers (AAF-g4.5-Peg)
synthesis
The synthesis of G4.5-PEG followed our previous work.21 
Upon removal of methanol from G4.5 PAMAM stock solu-
tion by rotary evaporation, G4.5 PAMAM dendrimer (5 mg) 
was dissolved in 2 mL of sodium PBS (0.1 M, pH = 5.5). To 
this solution were added 5.4 mg of EDC and 3.2 mg of NHS. 
After a 15 minute reaction at room temperature, 68.5 mg of 
PEG diamine (MW = ∼3350 g mol-1) predissolved in the International Journal of Nanomedicine 2010:5 27
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buffer solution was added to the reaction solution dropwise. 
Subsequently, 1.4 mg of AAF predissolved in the buffer was 
slowly added to the reaction solution. The reaction mixture 
solution was stirred in the dark overnight. The resultant 
AAF-G4.5-PEG nanoparticles were purified by dialysis and 
then freeze dried.
Proton nuclear magnetic resonance (1H-NMR) 
spectroscopy
The 1H-NMR spectra of dendrimer derivatives were recorded 
on a Varian Mercury-300 MHz NMR spectrometer (Varian, 
Palo Alto, CA). The solvent used was deuterium water (D2O), 
which has a chemical shift of 4.8 ppm.
Fluorescence spectroscopy
Fluorescence emission spectra of AAF and AAF-G4.5-PEG 
in water were recorded on a Varian Cary Eclipse fluorescence 
spectrophotometer with an excitation wavelength of 488 nm.
Preparation of macrophage–nanoparticle 
hybrid vehicles
As illustrated in Scheme 1, nanoparticles (QD525 or AAF-
G4.5-PEG) were coupled to the surface of macrophages via 
either a transient Schiff base linkage or a stable secondary 
amine linkage.
Macrophage–nanoparticle hybrids with a transient 
linkage (macrophage–T-nanoparticle hybrids)
RAW264.7 macrophages were plated on coverslips at a 
density of 1.2 × 104 cells/coverslip. At 70% confluence, 
the cells were treated with 0.1 mM cold NaIO4 in 100 µL 
of PBS (pH 7.4), incubated with shaking for 15 minutes at 
4 °C in the dark, and then rinsed with cold PBS three times to 
remove NaIO4.15 Following the NaIO4 treatment, the cells were 
incubated with 12 µg of nanoparticles dissolved in 100 µL of 
PBS for 0–24 hours. The resultant macrophage–T-nanoparticle 
hybrids were washed with PBS and incubated in PBS. 
At predetermined time points, macrophage–T-nanoparticle 
hybrids were fixed with 300 µL of 4% paraformaldehyde for 
fluorescence or confocal imaging. Untreated macrophages 
incubated with nanoparticles were used as a control.
Macrophage–nanoparticle hybrids with a stable 
linkage (macrophage–s-nanoparticle hybrids)
Macrophage–T-nanoparticle hybrids were further treated with 
100 µL of 0.1 mM NaCNBH3 for 1∼2 hours to convert the 
transient Schiff base linkages to stable amide linkages, washed 
with PBS, and incubated in PBS. At predetermined time 
points, macrophage–T-nanoparticle hybrids were fixed with 
4% paraformaldehyde for imaging. Untreated macrophages 
incubated with nanoparticles were used as a control.
pH-dependent cell viability assay
Since RAW264.7 macrophages were subjected to surface 
modification and the rate of the stablizing amide reaction is 
pH-dependent, the effect of pH of modifying solutions on 
the RAW264.7 macrophage viability was studied. In brief, 
RAW264.7 macrophages were initially incubated for two hours 
in media at different pH values, including DMEM (pH 7.4, 
control) and PBS (pH 8, pH 9 and pH 10, adjusted with sodium 
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hydroxide), washed with PBS (pH 7.4) three times, and grown 
in DMEM supplemented with 10% FBS and 5% penicillin for 
48 hours. Viable cells were counted by using the Trypan blue 
assay. In addition, toxicity of 0.1 mM NaCNBH3 in DMEM at 
pH 7.4 was also evaluated. Cell viability was then determined 
as follows: Cell viability (%) = total number of viable cells in 
each group/total number of viable cells in the control ×100.
Fluorescence image analysis
True-color fluorescence images of macrophage–nanoparticle 
hybrids were taken under a Zeiss Axiovert 200 inverted 
fluorescence microscope (Carl Zeiss AG, Oberkochen, 
Germany) or a Leica TCS-SP2 AOBS confocal laser scanning 
microscope (Lecia, Solms, Germany). DAPI nuclear stain 
was applied for colocalization of nanoparticles. Images were 
analyzed with ImageJ software (National Institutes of Health, 
Bethseda, MD).
Results and discussion
Preparation of macrophage–nanoparticle 
hybrids
In this study commercial QD525 coated with an amine-
derivatized PEG layer and synthesized PEGylated carboxyl 
terminated PAMAM dendrimer G4.5 were employed for 
hybridization with macrophages. PEGylated PAMAM den-
drimer G4.5 was labeled with AAF to allow confirmation of 
immobilization of nanoparticles on the cell surface by fluores-
cence imaging. Polyanionic PAMAM dendrimer G4.5 has a 
relatively high number of surface groups, negligible toxicity and 
immunogenicity, and favorable biodistribution.22 The negatively 
charged dendrimers have negligible cellular uptake due to their 
low non-specific interaction with the negatively charged cell 
surface. Inclusion of PEG provides dendrimers with favorable 
pharmacokinetic and tissue distribution and reduces potential 
accumulated toxicity and immunogenicity of the nanoparticles. 
Importantly, PEG helps nanoparticles to escape from phago-
cytosis of macrophages. This is a critical step for constructing 
the proposed hybrid delivery system. PEGylated dendrimers of 
larger molecular weight and with more branches tend to have a 
lower accumulation in cells as demonstrated previously.23
Similarly to the QD525 employed in this study, PEGylated 
G4.5 was designed to have amine-derivatized PEG chains 
on the surface, based on which cell surface modification 
chemistry was explored. PEGylated dendrimers have 
been well characterized previously.21,24–27 According to the 
1H-NMR measurement, an average of eight PEG chains 
were coupled to G4.5. PEGylated G4.5 was labeled with a 
moderately water-soluble fluorescence probe, AAF. As shown 
in Figure 1, AAF coupled to the dendrimer has an emission 
wavelength of 515 nm, which is identical to the emission 
wavelength of free AAF. The unaltered emission wavelength 
of AAF following this coupling strategy was also found in 
a previous report.28 Furthermore, the fluorescence emission 
intensity of AAF coupled to PEGylated G4.5 is significantly 
higher than that of AAF prepared in water at saturation, 
suggesting that AAF coupled to PEGylated G4.5 has higher 
water solubility than its unmodified form. The increase in 
the water solubility of AAF was attributed to the successful 
conjugation of AAF to the PEGylated dendrimer.
A number of methods have been developed to enable the 
chemical modification of cell surfaces. In this project, we 
employed a simple and well-documented methodology to 
immobilize nanoparticles to the macrophage cell surface. In 
particular, sialic acid residues embedded on the cell surface 
were converted to aldehydes with sodium periodate. Our 
results showed that the toxicity of NaIO4 was negligible at the 
concentration of 0.1 mM. This was supported by the work of 
Ong and coworkers.15 Aldehydes reacte with primary amine 
end groups of PEG on the nanoparticle surface to form Schiff 
bases. Schiff base linkage is labile and can be cleaved in 
aqueous solution by hydrolysis. Accordingly, the macrophage–
T-nanoparticle hybrids constructed are expected to readily 
release nanoparticles through the cleavage of the transient 
Schiff base linkages. We also applied a reducing agent 
sodium cyanoborohydride to reduce Schiff bases to stable 
secondary amine linkages.29 It has been reported that sodium 
cyanoborohydride has high specificity toward the Schiff base. 
According to our cell viability studies (Figure 2), sodium 
cyanoborohydride at 0.1 mM was nontoxic to RAW264.7 
macrophages. As the reaction proceeds more efficiently at 
basic pH,30 the viability of RAW264.7 macrophages at high pH 
(8–10) was evaluated to determine whether the immobilization 
chemistry can be performed at high pH. As shown in Figure 2, 
pH affects the cell viability. The viability of RAW264.7 mac-
rophages remains intact at pH 8 or pH 7.4 with 0.1 mM sodium 
cyanoborohydride. The cell viability dropped slightly to 88% 
at pH 9. By contrast, the viability was reduced drastically to 
52% at pH 10. The results suggest that mild basic pH has a 
minimal impact on the viability of RAW264.7 macrophages 
and the optimum pH within that range can be explored for 
increasing the immobilization efficiency.
Fluorescence image analysis  
of macrophage–Qdot hybrids
Fluorescence microcopy and confocal microscopy were 
applied to confirm the hybridization of nanoparticles International Journal of Nanomedicine 2010:5 29
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with  macrophages.  As  shown  in  Figure  3,  both 
macrophage–T-nanoparticle hybrids and macrophage–
S-nanoparticle hybrids prepared with QD525 exhibit strong 
fluorescence intensity at the edge of the cells, clearly outlin-
ing the cell surface. Qualitatively, more QD525 were taken 
up in macrophage–T-nanoparticle hybrids as opposed to 
macrophage–S-nanoparticle hybrids, reflecting the stability 
of the linkage between the nanoparticles and the cell. 
Confocal microscopy images in z-sections were taken to 
further examine the distribution of QD525 over the course 
of time. Without cell surface modification, QD525 were 
phagocytosed quickly and evenly distributed in the cytoplasm 
(Figure 4A – 4 h and 14 h). Although QD525 were still inter-
nalized, a significant amount of QD525 accumulated at the 
A
B
10 µm
10 µm
Figure 3 Fluorescence microscopy images of macrophage–Qdot hybrids. A) Macrophage–T-Qdot: macrophages treated with sodium periodate, incubated with QD525 for 
four hours, and fixed; B) Macrophage–s-Qdot: macrophages treated with sodium periodate, incubated with QD525 for four hours, treated with sodium cyanoborohydride, 
and fixed.
Notes: Original magnification, ×400; scale bar, 10 µm.
Abbreviation: Qdot, quantum dot.International Journal of Nanomedicine 2010:5 31
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4 h 14 h
A
B
C
20 µm
Figure 4 confocal microscopy images of macrophage–Qdot hybrids at four hours (left panel) or 14 hours (right panel) post-treatment. A) QD525 incubated with untreated 
macrophages (control); B) Macrophage–T-Qdot hybrids; C) Macrophage–s-Qdot hybrids.
Notes: Original magnification, ×630.
Abbreviation: Qdot, quantum dot.International Journal of Nanomedicine 2010:5 32
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edge of the cells treated with sodium periodate (Figure 4B) 
or a combination of sodium periodate and sodium cyanoboro-
hydride (Figure 4C). QD525 immobilized on the cell surface 
through a stable secondary amine bond displayed good stabil-
ity overnight (Figure 4C – 14 h). In contrast, QD525 linked 
to the cell surface via Schiff base linkages were found to be 
re-distributed in the cell overnight (Figure 4B – 14 h).
Fluorescence image analysis  
of macrophage–dendrimer hybrids
Macrophages hybridized with AAF-labeled PEGylated 
PAMAM dendrimer G4.5 were also studied. As shown in 
Figure 5A, the level of the internalization of AAF-G4.5-PEG 
by untreated macrophages is low. This confirmed that 
cationic surface charges and PEGylation indeed helped 
to reduce nonspecific internalization by macrophages. 
Further, an apparently biased distribution of AAF-G4.5-PEG 
nanoparticles was observed on the surface of macrophages 
that were treated with sodium perioate (Figure 5B) or the 
combination of sodium periodate and sodium cyanobo-
rohydride (Figure 5C). A significant increase in fluores-
cence intensity of macrophage–T-dendrimer hybrids and 
macrophage–S-dendrimer hybrids as compared to the control 
suggests that more dendrimer nanoparticles have been immo-
bilized to the cell surface and/or internalized by the cells. The 
amine linkages connecting dendrimers to the cell enabled 
macrophage–S-dendrimer hybrids to carry dendrimers 
stably on the surface for an extended period of time. We also 
observed that when the surface-treated macrophages were 
incubated with the same amount of AAF-G4.5-PEG (12 µg), 
a condition of a high concentration (12 µg/100 µL) and a 
short incubation (one minute) was relatively equivalent to a 
condition of a low concentration (12 µg/1.5 mL) and a long 
incubation (10 minutes) in terms of hybridization efficiency 
as determined by confocal image analysis. Cell viability 
remained good during the surface treatment.
To further evaluate the intracellular localization of 
nanoparticles, we performed a colocalization assay on 
AAF-G4.5-PEG with nuclear DAPI staining. Clearly shown 
in Figure 6A, a significant amount of AAF-G4.5-PEG 
nanoparticles were internalized within one-minute incuba-
tion and accumulated evenly in the cytoplasma with no 
selectivity towards the cell surface after overnight culture. 
Entry of the nanoparticles into nuclei was also observed 
in the macrophages. This became more evident when the 
cells were incubated with AAF-G4.5-PEG for an extended 
period of time (overnight incubation, Figure 6B). In addition, 
more nanoparticles were internalized by the cells following 
20 µm
A
B
C
Figure 5 confocal microscopy images of macrophage–dendrimer hybrids. 
A) Untreated macrophages incubated with AAF-g4.5-Peg for 10 minutes and 
fixed immediately (control); B) Macrophage–T-dendrimer hybrids fixed immediately 
following 10-minute incubation with AAF-G4.5-PEG; C) Macrophage–s-dendrimer 
hybrids fixed at 14 hours following treatment of sodium cyanoborohydride. Original 
magnification, ×630.International Journal of Nanomedicine 2010:5 33
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A
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D
5 µm 
AAF DAPI Merge
Figure 6 colocalization assay of AAF-g4.5-Peg (green) with nuclei (blue) by confocal microscopy. A) control 1: untreated macrophages incubated with AAF-g4.5-Peg for 
one minute, washed and cultured overnight (24 hours), then fixed and counterstained with DAPI; B) control 2: untreated macrophages incubated with AAF-g4.5-Peg over-
night (24 hours), then fixed and counterstained with DAPI; C) Macrophage–T-dendrimer hybrids: sodium periodate-treated macrophages incubated with AAF-g4.5-Peg for 
one minute, cultured overnight (24 hours), then fixed and counterstained with DAPI; D) Macrophage–s-dendrimer hybrids: sodium periodate-treated macrophages incubated 
with AAF-G4.5-PEG for one minute, treated with sodium cyanoborohydride, cultured overnight (24 hours), then fixed and counterstained with DAPI.
Notes: Original magnification, ×630.International Journal of Nanomedicine 2010:5 34
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the overnight incubation as indicated by the increase in the 
fluorescence intensity. Macrophage–S-dendrimer hybrids 
(Figure 6D) show a stronger fluorescence intensity at the 
cell surface and less in nuclei as compared to macrophage–
T-dendrimer hybrids (Figure 6C), confirming that the stability 
of immobilized dendrimers in macrophage–S-dendrimer 
hybrids was higher than macrophage–T-dendrimer hybrids.
It is apparent that fluorescently labeled nanoparticles 
were taken into the macrophages after each treatment. 
Qualitatively, there is a uniform distribution of fluorescence 
throughout the untreated control groups, suggesting cel-
lular uptake pathways are responsible for this occurrence. 
Following surface modification, a pronounced ring of fluo-
rescence is observed towards the cell surface. Quantitative 
analysis of the distribution of nanoparticle fluorescence was 
attempted with the intensity profile generated by ImageJ 
software (Figure 7). Since all confocal images were taken 
under identical image acquisition settings, the fluorescence 
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intensity profiles generated allowed us to quantitatively 
analyze fluorescence distribution in individual cells based 
on their relative fluorescence intensity. For each group, three 
representative cells were chosen and analyzed. Individual 
cells were measured three times from different orientations 
with each orientation approximately bisecting midlines. From 
each profile, intensity values were recorded from fluorescence 
peaks at the two cell boundaries and from a fluorescence peak 
near the midline of each trace. The results are summarized in 
Table 1. The results from the intensity traces show that for a 
nanoparticle incubation of one minute, there is 20.8% more 
fluorescence at the cell boundaries versus the cell center. For 
an overnight incubation, there was an even distribution of fluo-
rescent intensity where the cell walls exhibited a fluorescence 
value that was 99.8% of the fluorescence of the midpoint of 
the slice. Surface modification drastically increased the ratio 
of fluorescence between the cell walls versus the cell interior. 
The macrophage–T-nanoparticle hybrids showed an 85.2% 
increase in fluorescence near the cell exterior, whereas the 
macrophage–S-nanoparticle hybrids showed a 94.4% increase 
in cell wall fluorescence. Based on these measurements we 
show that there is markedly more fluorescence near the cell 
surface for surface-treated groups, whereas there is an even 
distribution of nanoparticles in the control groups.
From a chemistry perspective, this work demonstrated 
the proof-of-principle of chemically hybridizing macro-
phages with nanoparticles through cell surface modification. 
The reaction conditions explored in this study were mild to 
the cells. It should be noted that internalization of nanopar-
ticles by macrophages seems to be an inevitable process 
because of their innate phagocytic capability. Nonetheless, 
our studies disclosed that cell surface modification provides 
a means to retard the internalization progress and alter the 
intracellular distribution of nanoparticles. A comprehensive 
understanding of the trafficking and dynamic distribution 
of nanoparticles is needed in order for us to optimize the 
hybridization process. Reducing nonspecific phagocytic 
internalization of nanoparticles will be pursued in our labo-
ratory. The sizes of the Qdots and PAMAM dendrimers as 
an important factor affecting nanoparticle internalization by 
cells will be studied. PAMAM dendrimers have a versatile 
structure ideal for construction of drug delivery systems 
and have been extensively studied by many groups includ-
ing us.31–34 Future work will include hybridization of drug-
carrying dendrimers and/or QD525 with macrophages and 
studying the delivery efficiency of such a new drug vehicle 
in terms of drug distribution in hypoxic areas using in vitro 
spheroid models and animal models.
Conclusions
QD525 and dendrimers were immobilized to the macrophage 
cell surface through either a transient Schiff base linkage 
or a stable amine linkage. The distribution of nanoparticles 
on the cell surface was confirmed by fluorescence imaging 
and was found to be dependent on the stability of the link-
ages connecting nanoparticles to the cell surface. Achieving 
homogeneous distribution of anticancer drugs within tumors 
remains one of the major challenges in cancer chemotherapy 
and is critical for treatment effectiveness. The current study 
has explored an innovative way of utilizing nanoparticles and 
cellular vehicles for anticancer drug delivery. Development 
of a cell–nanoparticle hybrid vehicle through cell surface 
modification would utilize the best aspects of both cellular 
carriers and nanoparticles and may help to improve anticancer 
drug distribution and penetration in tumors.
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